ID   AML14.3D10/CCCKR3 Clone 16
AC   CVCL_6337
SY   AML14/CCCKR3.16
DR   CLO; CLO_0001717
DR   ATCC; CRL-12079
DR   BioSample; SAMN03471345
DR   Wikidata; Q54749808
RX   Patent=US6271347;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12079.
CC   Transfected with: HGNC; 1604; CCR3.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Discontinued: ATCC; CRL-12079; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-12079
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 10,14
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0141 ! AML14.3D10
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
RX   Patent=US6271347;
RA   Daugherty B.L., Demartino J.A., Siciliano S.J., Springer M.S.;
RT   "Eosinophil eotaxin receptor.";
RL   Patent number US6271347, 07-Aug-2001.
//